HEALTHJul 24 · 15:19 UTCTHE ATLANTICTom Bartlett

The Peptide Gold Rush Is Coming

BPC-157, a peptide rumored to treat various conditions, has gained popularity through influencers and Robert F. Kennedy Jr. An FDA advisory committee recommended allowing compounding pharmacies to produce it despite limited safety data. Telehealth companies may soon offer it if the FDA approves the recommendation.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

BPC-157topicFDAorganizationRobert F. Kennedy Jr.personPharmacy Compounding Advisory CommitteeorganizationTelehealth companiesorganizationpeptidestopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 23 · 13:18 UTC
The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.
HEALTHJul 20 · 11:27 UTC
The FDA’s peptide vote could create telehealth’s next multibillion-dollar market
HEALTHJul 24 · 00:15 UTC
FDA considers widening access to popular peptides